NCT03191630
- Conditions
- Behavior, Cardiorenal; Change, Cardiovascular Diseases, +3 more
- Locations
-
- The Ohio State University Wexner Medical Center, Kidney Transplant Program Columbus, Ohio, United States
Clinical trial condition
Cardiovascular Diseases
Explore clinical trials studying Cardiovascular Diseases. Study availability and eligibility vary by location and protocol.
4,252 public trials
554 recruiting studies
Cardiovascular Diseases trial results
NCT03496948
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +5 more
- Locations
-
- TK statutory health insurance Hamburg, Germany
- KKH statutory health insurance Hanover, Germany
- Mhplus Statutory Health Insurance Nuremberg, Germany
NCT03345927
- Conditions
- Cardiovascular Diseases
- Locations
-
- Chun Wang Shenzhen, Guangdong, China
NCT01848886
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +6 more
- Locations
-
- Rigshospitalet Copenhagen, Denmark
Completed
Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain
NCT02142452
- Conditions
- Body Weight, Body Weight Changes, Cardiovascular Diseases, +9 more
- Locations
-
- Stanford Hospital and Clinics Stanford, California, United States
Completed
Utility of the SomaLogic Cardiovascular Disease (CVD) Secondary Risk Panel for Cardiovascular Risk
NCT03599531
- Conditions
- Cardiovascular Diseases, Cardiovascular Risk Factor
- Locations
-
- Boulder Heart Boulder, Colorado, United States
NCT04357301
- Conditions
- Cardiovascular Diseases
- Locations
-
- Erasme Brussels, Belgium
NCT00001458
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Statin Therapy and COVID-19 Infection
NCT04407273
- Conditions
- COVID, Cardiovascular Diseases, Statin
- Locations
-
- Facultat de Medicina i Ciències de la Salut de Reus Reus, Tarragona, Spain
NCT00844376
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States